Rhythm Pharmaceuticals Presents Patient-reported : compareme

Rhythm presents first-ever hypothalamic obesity patient-reported experiences with hyperphagia and positive changes in energy and sleep at ENDO2024 ...

Related Keywords

United Kingdom , United States , Boston , Massachusetts , Michigan , David Connolly , Caroline Huber , David Meeker , Adam Daley , Christian Roth , Danica Grujic , European Union , Energy In Acquired Hypothalamic Obesity , Seattle Children Research Institute , Corporate Communications , Berry Company Public Relations , Rhythm Pharmaceuticals , Nasdaq , Clinical Development , Rhythm Pharmaceuticals Inc , Division Of Metabolism , Division Of Endocrinology , Department Of Pediatrics , University Of Washington , Medicines Healthcare Products Regulatory Agency , Exchange Commission , Translational Research Development , Endocrine Society Annual Meeting Expo , European Commission , University Of Michigan , Drug Administration , Endocrine Society Annual Meeting , Chief Executive Officer , Seattle Children , Research Institute , Caregiver Reported Experiences , Acquired Hypothalamic Obesity Before , During Setmelanotide Therapy , Senior Director , Non Clinical Development , Translational Research , Associate Professor , Real World Evidence , Chronic Weight Management , Healthcare Products Regulatory Agency , Pre Existing Nevi , Sexual Arousal , Suicidal Ideation , Serious Adverse Reactions Due , Benzyl Alcohol Preservative , Low Birth Weight Infants , Yellow Card Scheme , Product Characteristics , Prescribing Information , Important Safety , Private Securities Litigation Reform Act , Quarterly Report , Investor Relations ,